Independent · Beginner-Friendly · Data-Driven
3 articles found
The 12 metrics every investor must check before buying a pharma stock, explained simply with Indian examples from Sun Pharma, Cipla, and Dr. Reddy's.
A deep-dive analysis of Natco Pharma using all 12 pharma-specific metrics — revenue mix, FDA compliance, Para IV pipeline, return ratios, and valuation — at a time when the stock sits 28% off its 52-week high.
Master P/E ratios, PEG, P/B, and EV/EBITDA with real examples from TCS, HDFC Bank, Google, and NVIDIA. Includes Indian market sector benchmarks.
